Results 1 to 10 of about 2,248,395 (203)

Machine Learning System for Lung Neoplasms Distinguished Based on Scleral Data. [PDF]

Diagnostics (Basel), 2023
Lung cancer remains the most commonly diagnosed cancer and the leading cause of death from cancer. Recent research shows that the human eye can provide useful information about one’s health status, but few studies have revealed that the eye’s features ...
Huang Q, Lv W, Zhou Z, Tan S, Lin X, Bo Z, Fu R, Jin X, Guo Y, Wang H, Xu F, Huang G.   +11 more
europepmc   +2 more sources

Dual targeting PET tracer [⁶⁸Ga]Ga-FAPI-RGD in patients with lung neoplasms: a pilot exploratory study. [PDF]

Theranostics, 2023
Rationale: Early discovery, accurate diagnosis, and staging of lung cancer is essential for patients to receive appropriate treatment. PET/CT has become increasingly recognized as a valuable imaging modality for these patients, but there remains room for
Wang R, Jakobsson V, Wang J, Zhao T, Peng X, Li B, Xue J, Liang N, Zhu Z, Chen X, Zhang J.   +10 more
europepmc   +2 more sources

Primary lung neoplasms presenting as multiple synchronous lung nodules. [PDF]

Eur Respir Rev, 2020
Multiple synchronous lung nodules are frequently encountered on computed tomography (CT) scanning of the chest and are most commonly either non-neoplastic or metastases from a known primary malignancy.
Ghosh S, Mehta AC, Abuquyyas S, Raju S, Farver C.   +4 more
europepmc   +2 more sources

The Surgical Management of Lung Neuroendocrine Neoplasms [PDF]

Cancers, 2023
Simple Summary Lung neuroendocrine neoplasms comprise a diverse group of cancers that arise from pulmonary neuroendocrine cells. They account for about 20% of all primary lung cancers and classify into four subtypes: typical carcinoid, atypical carcinoid,
Patrick Soldath, R. Petersen
semanticscholar   +4 more sources

Epigenome-wide association study of smoking and DNA methylation in non-small cell lung neoplasms. [PDF]

Oncotarget, 2016
Tobacco smoke is a well-established lung cancer carcinogen. We hypothesize that epigenetic processes underlie carcinogenesis. The objective of this study is to examine the effects of smoke exposure on DNA methylation to search for novel susceptibility ...
Freeman JR, Chu S, Hsu T, Huang YT.
europepmc   +2 more sources

Targeted sequencing reveals clonal genetic changes in the progression of early lung neoplasms and paired circulating DNA. [PDF]

Nat Commun, 2015
Lungs resected for adenocarcinomas often harbour minute discrete foci of cytologically atypical pneumocyte proliferations designated as atypical adenomatous hyperplasia (AAH).
Izumchenko E, Chang X, Brait M, Fertig E, Kagohara LT, Bedi A, Marchionni L, Agrawal N, Ravi R, Jones S, Hoque MO, Westra WH, Sidransky D.   +12 more
europepmc   +2 more sources

mTOR in Lung Neoplasms

Pathology & Oncology Research, 2020
With the discovery of rapamycin 45 years ago, studies in the mechanistic target of rapamycin (mTOR) field started 2 decades before the identification of the mTOR kinase. Over the years, studies revealed that the mTOR signaling is a master regulator of homeostasis and integrates a variety of environmental signals to regulate cell growth, proliferation ...
I. Krencz, A. Sebestyén, A. Khoor
semanticscholar   +4 more sources

Gene therapy for lung neoplasms. [PDF]

Clin Chest Med, 2011
The field of gene therapy is still in its infancy, but significant accomplishments have been achieved. The ability to transfer genes safely and successfully into animals and patients clearly has been established. It is highly likely that in the near future, gene therapy will be shown to have clear therapeutic efficacy in diseases such as the treatment ...
Vachani A, Moon E, Wakeam E, Haas AR, Sterman DH, Sterman DH, Albelda SM.   +6 more
europepmc   +6 more sources

A molecular map of lung neuroendocrine neoplasms [PDF]

GigaScience, 2020
Background Lung neuroendocrine neoplasms (LNENs) are rare solid cancers, with most genomic studies including a limited number of samples. Recently, generating the first multi-omic dataset for atypical pulmonary carcinoids and the first methylation ...
Aurélie A G Gabriel, Emilie Mathian, L. Mangiante, C. Voegele, Vincent Cahais, A. Ghantous, J. Mckay, N. Alcala, L. Fernandez-Cuesta, M. Foll   +9 more
semanticscholar   +4 more sources

Adjuvant therapy for lung neuroendocrine neoplasms

World Journal of Clinical Oncology, 2021
Pulmonary neuroendocrine neoplasms (NENs) represent a minority of lung cancers and vary from slower growing pulmonary carcinoid (PC) tumors to aggressive small cell lung cancer (SCLC). While SCLC can account for up to 15% of lung cancer, PCs are uncommon and represent about 2% of lung cancers.
Robert A. Ramirez, Katharine Thomas, Aasems Jacob, Karen Lin, Yvette Bren‐Mattison, Aman Chauhan   +5 more
openalex   +3 more sources